KIAA1199 expression by activated astrocytes may explain the focal HA degradation observed during progression of MS and could represent a possible new therapeutic target.
KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions
https://academic.oup.com/glycob/article/28/12/958/5052028
